Clear-cell carcinoma of the ovary

被引：72
作者：
Fujiwara, K. [1 ]
Shintani, D. [1 ]
Nishikawa, T. [1 ]
机构：
[1] Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka City, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
GYNECOLOGIC-ONCOLOGY-GROUP; ADJUVANT CHEMOTHERAPY; CANCER; ADENOCARCINOMA; IDENTIFICATION; CISPLATIN; TARGET; JAPAN;
D O I：
10.1093/annonc/mdw086
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Clear-cell carcinoma of the ovary (CCCO) is a distinct entity of epithelial ovarian cancer in terms of clinical, histopathological, or genetic features. The incidence of CCCO is different by ethnicity but the reason is not clear yet. Overall prognosis of CCCO is good because most CCCO is found in stage I. However, advanced disease is associated with a very poor prognosis and resistance to standard treatment. The same is true for recurrent disease. Therefore, genetic analysis of CCCO is important to find the right target(s) and better therapeutic approaches. Because of its rarity, international collaboration is necessary to conduct randomized clinical trials for CCCO.
引用
收藏
页码：50 / 52
页数：3
相关论文
共 18 条
  • [1] Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
    Anglesio, Michael S.
    Carey, Mark S.
    Koebel, Martin
    MacKay, Helen
    Huntsman, David G.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 121 (02) : 407 - 415
  • [2] Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation
    Hoskins, Paul J.
    Le, Nhu
    Gilks, Blake
    Tinker, Anna
    Santos, Jennifer
    Wong, Frances
    Swenerton, Kenneth D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) : 1656 - 1662
  • [3] WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma
    Kaneuchi, M
    Sasaki, M
    Tanaka, Y
    Shiina, H
    Yamada, H
    Yamamoto, R
    Sakuragi, N
    Enokida, H
    Verma, M
    Dahiya, R
    [J]. CANCER, 2005, 104 (09) : 1924 - 1930
  • [4] Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
    Katsumata, Noriyuki
    Yasuda, Makoto
    Takahashi, Fumiaki
    Isonishi, Seiji
    Jobo, Toshiko
    Aoki, Doisuke
    Tsuda, Hiroshi
    Sugiyama, Toru
    Kodama, Shoji
    Kimura, Eizo
    Ochiai, Kazunori
    Noda, Kiichiro
    [J]. LANCET, 2009, 374 (9698) : 1331 - 1338
  • [5] Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan
    Kobayashi, H.
    Sumimoto, K.
    Moniwa, N.
    Imai, M.
    Takakura, K.
    Kuromaki, T.
    Morioka, E.
    Arisawa, K.
    Terao, T.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (01) : 37 - 43
  • [6] mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
    Mabuchi, Seiji
    Kawase, Chiaki
    Altomare, Deborah A.
    Morishige, Kenichirou
    Sawada, Kenjiro
    Hayashi, Masami
    Tsujimoto, Masahiko
    Yamoto, Mareo
    Klein-Szanto, Andres J.
    Schilder, Russell J.
    Ohmichi, Masahide
    Testa, Joseph R.
    Kimura, Tadashi
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5404 - 5413
  • [7] Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: A Japanese Gynecologic Oncology Group (JGOG)/GCIG study.
    Okamoto, Aikou
    Sugiyama, Toru
    Hamano, Tetsutaro
    Kim, Jae Weon
    Kim, Byoung Gie
    Enomoto, Takayuki
    Aoki, Daisuke
    Terao, Yasuhisa
    Suzuki, Nao
    Mikami, Mikio
    Yaegashi, Nobuo
    Kato, Kiyoko
    Yoshikawa, Hiroyuki
    Pignata, Sandro
    Alexandre, Jerome
    Green, John A.
    Isonishi, Seiji
    Terauchi, Fumitoshi
    Fujiwara, Keiichi
    Ochiai, Kazunori
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary
    Okamoto, Aikou
    Glasspool, Rosalind M.
    Mabuchi, Seiji
    Matsumura, Noriomi
    Nomura, Hiroyuki
    Itamochi, Hiroaki
    Takano, Masashi
    Takano, Tadao
    Susumu, Nobuyuki
    Aoki, Daisuke
    Konishi, Ikuo
    Covens, Alan
    Ledermann, Jonathan
    Mezzazanica, Delia
    Steer, Christopher
    Millan, David
    McNeish, Iain A.
    Pfisterer, Jacobus
    Kang, Sokbom
    Gladieff, Laurence
    Bryce, Jane
    Oza, Amit
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : S20 - S25
  • [9] Sato N, 2000, CANCER RES, V60, P7052
  • [10] Sekizawa Akihiko, 2004, Medical Electron Microscopy, V37, P97
12